Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $760 | $360 | $480 | $749 |
| Short-Term Investments | $97 | $477 | $524 | $488 |
| Receivables | $311 | $287 | $292 | $331 |
| Inventory | $149 | $141 | $139 | $142 |
| Other Curr. Assets | $36 | $30 | $27 | $28 |
| Total Curr. Assets | $1,352 | $1,296 | $1,462 | $1,738 |
| Property Plant & Equip (Net) | $397 | $330 | $317 | $339 |
| Goodwill | $9 | $10 | $0 | $0 |
| Intangibles | $31 | $36 | $7 | $12 |
| Long-Term Investments | $400 | $448 | $447 | $456 |
| Tax Assets | $13 | $11 | $10 | $10 |
| Other NC Assets | $75 | $65 | $62 | $75 |
| Total NC Assets | $924 | $900 | $842 | $892 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,277 | $2,197 | $2,305 | $2,630 |
| Liabilities | – | – | – | – |
| Payables | $94 | $109 | $8,351 | $7,533 |
| Short-Term Debt | $10 | $359 | $1,398 | $1,372 |
| Tax Payable | $0 | $1,889 | $17 | $26 |
| Deferred Revenue | $19 | $30 | $43 | $26 |
| Other Curr. Liab. | $191 | -$2,081 | -$9,497 | -$8,677 |
| Total Curr. Liab. | $313 | $307 | $313 | $279 |
| LT Debt | $16 | $5 | $153 | $227 |
| Deferred Rev, NC | $0 | $4 | $6 | $8 |
| Deferred Tax Liab, NC | $29 | $30 | $1,813 | $4,170 |
| Other NC Liab. | $65 | $71 | $10,225 | $10,558 |
| Total NC Liab. | $109 | $105 | $95 | $137 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $354 | $333 | $309 |
| Total Liabilities | $422 | $412 | $407 | $416 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $56 | $57 | $62 | $74 |
| Retained Earnings | $1,711 | $1,621 | $1,729 | $2,051 |
| AOCI | $347 | $324 | $273 | $223 |
| Other Equity | -$278 | -$231 | -$182 | -$149 |
| Total Equity | $1,837 | $1,770 | $1,882 | $2,198 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $17 | $15 | $15 | $15 |
| Total Liab. & Tot. Equity | $2,277 | $2,197 | $2,305 | $2,630 |
| Net Debt | -$734 | $4 | $1,070 | $850 |